EU Approves Two More Manufacturing Sites for Pfizer-BioNTech Covid Vaccine
June 22 2021 - 9:19AM
Dow Jones News
By Cecilia Butini
The European Medicines Agency said Tuesday that its committee
for human medicines has approved two additional manufacturing sites
for the production of the coronavirus vaccine developed by BioNTech
SE and Pfizer Inc.
The sites are in Reinbek, Germany, and Stein, Switzerland, and
are operated by Allergopharma GmbH & Co. KG. and Novartis
Pharma, respectively.
The sites are to become operational immediately, the agency
said.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
June 22, 2021 09:08 ET (13:08 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2023 to Apr 2024